Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients

Neoplasma

Volumn 58, Issue 4, 2011, Pages 298-303

  Jamaspishvili, T ^a   Scorilas, A ^c   Kral, M ^b   Khomeriki, I ^b   Kurfurstova, D ^a   Kolar, Z ^a   Bouchal, J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Immunohistochemical analysis; Kallikrein related peptidases; KLK11; KLK7; Prostate specific antigen; Prostate specific membrane antigen

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; KLK7 PROTEIN, HUMAN; SERINE PROTEINASE; TRYPSIN LIKE SERINE PROTEASE; TRYPSIN-LIKE SERINE PROTEASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; BIOSYNTHESIS; ENZYMOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

AGED; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 80052546085     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_04_298     Document Type: Article

References (27)

1. J. DAMBER, G. AUS. Prostate cancer. Lancet 2008; 371: 1710-21. doi:10.1016/S0140-6736(08)60729-1
2. E.P. DIAMANDIS, G.M. YOUSEFf, J. CLEMENTS, L.K. ASHWORTH, S. YOSHIDA et al. New nomenclature for the human tissue kallikrein gene family. Clin Chem 2000; 46: 1855-8.
3. S.J. FREEDLAND, A.W. PARTIN. Prostate-specific antigen: update 2006. Urology 2006; 67: 458-60. doi:10.1016/j.urology.2005.12.026
4. S.F. SHARIAT, J.A. KARAM, V. MARGULIS, P.I. Karakie-Wicz. New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer. BJU Int 2008; 101: 675-83. doi:10.1111/j.1464-410X.2007.07283.x
5. F.H. JANSEN, R.H. VAN SCHALK, J. KURSTJENS, W. HORNINGER, H. KLOCKER et al. Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection. Eur Urol 2010; (Epub ahead of print). doi:10.1016/j.eururo.2010.02.003
6. G.M. YOUSEF, E.P. Diamandis. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 2001; 22: 184-204. doi:10.1210/er.22.2.184
7. E.P. DIAMANDIS, A. OKUI, S. MITSUI, L.Y. LUO, A. Soosai-Pillai, L et al. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res 2002; 62: 295-300.
8. C.V. Obiezu, E.P. DIAMANDIS. Human tissue kallikrein gene family: applications in cancer. Cancer Lett 2005; 224: 1-22.
9. G.M. YOUSEF, C.V. OBIEZU, L.Y. LUO, A. MAGKLARA, C.A. BORGONO et al. Human tissue kallikreins: from gene structure to function and clinical applications. Adv Clin Chem 2005; 39: 11-79. doi:10.1016/S0065-2423(04)39002-5
10. S.J. SHAN, A. SCORILAS, D. KATSAROS, I. RIGAULTT DE LA LONGRAIS, M. MASSOBRIO et al. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols. Clin Chem 2006; 52: 1879-86. doi:10.1373/clinchem.2006.071456
11. X. LI, J. LIU, Y. WANG, L. ZHANG, L. NING et al. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies. Cancer Sci 2009; 100: 601-7. doi:10.1111/j.1349-7006.2009.01090.x
12. Q. XUAN, X. YANG, L. MO, F. HUANG, Y. PANG et al. Expression of the serine protease kallikrein 7 and its inhibitor antileukoprotease is decreased in prostate cancer. Arch Pathol Lab Med 2008; 132: 1796-801.
13. T. NAKAMURA, S. MITSUI, A. OKUI, K. KOMINAMI, T. NOMOTO et al. Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines. Prostate 2001; 49: 72-8. doi:10.1002/pros.1119
14. T. NAKAMURA, S. MITSUI, A. OKUI, T. MIKI, N. YAMAGUCHI. Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate. Prostate 2003; 54: 299-305. doi:10.1002/pros.10191
15. E.P. DIAMANDIS, G.M. YOUSEF. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 2002; 48: 1198-205.
16. A. SCORILAS, A.K. GREGORAKIS. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. Biol Chem 2006; 387: 789-93. doi:10.1515/BC.2006.099
17. T. NAKAMURA, A. SCORILAS, C. STEPHAN, K. JUNG, A.R. Soosaipillai et al. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res 2003; 63: 6543-6.
18. S.S. CHAMG. Overview of prostate-specific membrane antigen. Rev Urol 2004; 6 Suppl 10 S13-8.
19. P. Mhawech-Fauceglia, S. ZHANG, L. TERRACCIANO, G. SAUTER, A. CHADHURI et al. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique. Histopathology 2007; 50: 472-83. doi:10.1111/j.1365-2559.2007.02635.x
20. G.P. MURPHY, A.A. ELGAMAL, S.L. SU, D.G. BOSTWICK, E.H. Holmes. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Cancer 1998; 83: 2259-69. doi:10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T
21. S. PERNER, M.D. HOFER, R. KIM, R.B. SHAH, H. LI et al. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol 2007; 38: 696-701. doi:10.1016/j.humpath.2006.11.012
22. S. TROUP, C. NJUE, E.V. KLIEWER, M. PARISIEN, C. ROSKELLEY et al. Reduced expression of the small leucinerich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 2003; 9: 207-14.
23. T. NAKAMURA, C. STEPHAN, A. SCORILAS, G.M. YOUSEF, K. JUNG et al. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology 2003; 61: 1042-6. doi:10.1016/S0090-4295(02)02443-3
24. X. BI, H. HE, Y. YE, Q. DAI, Z. HAN et al. Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Med Oncol 2010; 27: 145-51. doi:10.1007/s12032-009-9185-0
25. P. STAVROPOULOU, A.K. GREGORAKIS, M. PLEBANI, A. SCORILAS. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer. Clin Chim Acta 2005; 357: 190-5. doi:10.1016/j.cccn.2005.03.026
26. E.G. WEIR, A.W. PARTIN, J.I. EPSTEIN. Correlation of serum prostate specific antigen and quantitative immunohistochemistry. J Urol 2000; 163: 1739-42. doi:10.1016/ S0022-5347(05)67532-5
27. A. ERBERSDOBLER, H. ISBARN, I. STEINER, T. SCHLOMM, F. CHUN et al. Predictive value of prostatespecific antigen expression in prostate cancer: a tissue microarray study. Urology 2009; 74: 1169-73. doi:10.1016/j.urology.2009.02.061